Congressional Hearing On the Reimbursement of Biosimilars Draws Criticism of CMS’s Existing Payment Policy

By | Health Law Pulse | February 5, 2016
Congressional Hearing On the Reimbursement of Biosimilars Draws Criticism of CMS’s Existing Payment Policy

On February 4th, the Energy & Commerce Committee’s subcommittee on health held a legislative hearing regarding the implementation of the Biologics Price Competition and Innovation Act, which established a shortened FDA approval process for determining when biosimilar products are considered interchangeable with previously-approved FDA products. 

Tweet Like LinkedIn LinkedIn Google Plus

Latest OCR Enforcement Action: Underbed Storage is Not Appropriate for PHI

By | Health Law & Policy Matters | February 4, 2016

Recent enforcement actions by the U.S. Department of Health and Human Services (“HHS”) Office for Civil Rights (“OCR”) have highlighted that, not surprisingly, Covered Entities should not leave medical records in a physician’s driveway and should not dispose of protected health information (“PHI”) in a dumpster.

Tweet Like LinkedIn LinkedIn Google Plus

New CMS Rule Permits Home Health Face-to-Face Encounters to Occur Through Telehealth Technology

By | Covington eHealth | February 4, 2016

Earlier this week, the Centers for Medicare & Medicaid Services (CMS) finalized a rule implementing a provision of the Affordable Care Act (ACA) that requires a Medicaid enrollee seeking coverage for home health services to first meet face-to-face with a practitioner. 

Tweet Like LinkedIn LinkedIn Google Plus